Medindia

X

Dutch Pharma Firm to Invest $500 mn in India

by Medindia Content Team on  August 24, 2006 at 11:41 AM Corporate News   - G J E 4
Dutch Pharma Firm to Invest $500 mn in India
DSM Anti-Infectives, a $20 billion pharma firm based in the Netherlands, Wednesday said it would invest $500 million in India and hoped to capture a 10 percent share of the country's antibiotics market.
Advertisement

"We are continuously exploring opportunities to invest in India. Currently, our sales in India is $100 million per annum," said company president Gerard Reuver, launching a new penicillin-based antibiotic, Purimox, in the country.

Advertisement
"We plan to invest half a billion dollars in various other innovations," he said here at the opening of a new manufacturing plant to produce Purimox that is used to manufacture a variety of drugs.

The facility was inaugurated by the Netherlands Ambassador to India Eric F. CH. Niehe and Punjab's Minister for Technical Education R.C. Dogra.

N.V. Ramanna, vice president of the Dutch company, said the present size of the plant was 2,000 tonnes and would be expanded soon by another 3,000 tonnes. "We plan to achieve a market share of 10 percent in the antibiotic market this fiscal."

A company official said Purimox produces amoxicillin using an enzymatic route and does not use solvents, which leads to a product of higher purity.

(Source: IANS)
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
pls give address of dutch pharma in india
guest Tuesday, October 10, 2006

You May Also Like

Advertisement
View All

More News on: